Advanced or Metastatic Non-small Cell Lung Cancer Clinical Trials in Beijing, Beijing Municipality
5 recruitingBeijing, Beijing Municipality, China
Showing 1–5 of 5 trials
Recruiting
Phase 2
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
Locally Advanced or Metastatic ER+ HER2- Breast CancerLocally Advanced or Metastatic Castration-resistant Prostate CancerLocally Advanced or Metastatic Non-small Cell Lung Cancer
Pfizer320 enrolled44 locationsNCT04606446
Recruiting
Phase 1Phase 2
A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer
Advanced or Metastatic Non-small Cell Lung Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd.248 enrolled1 locationNCT06512051
Recruiting
Phase 1Phase 2
A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
Advanced Malignant NeoplasmAdvanced or Metastatic Non-small Cell Lung Cancer
SUNHO（China）BioPharmaceutical CO., Ltd.78 enrolled1 locationNCT06581419
Recruiting
Phase 3
Furmonertinib 160mg as First-line Treatment in Locally Advanced or Metastatic NSCLC With EGFR Classical Mutations
Advanced or Metastatic Non-small Cell Lung Cancer
Peking Union Medical College Hospital144 enrolled1 locationNCT06674343
Recruiting
Phase 1Phase 2
A Study of XZP-5955 Tablets in Patients With NTRK or ROS1 Fusion Positive Locally Advanced or Metastatic Solid Tumors
Locally Advanced or Metastatic Non-small Cell Lung CancerLocally Advanced or Metastatic Solid Tumors
Xuanzhu Biopharmaceutical Co., Ltd.360 enrolled1 locationNCT04996121